Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

FIRST: Eli Lilly begins human trial of potential antibody treatment for COVID-19

Ruchika Sharma4 Jun 2020 9:30 AM IST

This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Eli Lilly and AbCellera to create...

Russia nod to COVID-19 drug Avifavir good news for India, say scientists

Ruchika Sharma4 Jun 2020 9:15 AM IST

It also said Avifavir has become the first Favipiravir-based drug in the world to be approved for the treatment of COVID-19, it said.

Lupin gets USFDA approval for Meloxicam to treat osteoarthritis pain

Ruchika Sharma3 Jun 2020 10:45 AM IST

Meloxicam Capsules, 5 mg and 10 mg, are indicated for the management of osteoarthritis (OA) pain

Granules JV in India OmniChem acquired by Ajinomoto Bio-Pharma

Ruchika Sharma3 Jun 2020 10:30 AM IST

The transaction, announced in August 2019, strengthens Aji Bio-Pharma's commitment to providing its clients accessibility to a reliable and simplified...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Zydus Wellness Net Profit rises 11 pc to Rs 69.10 crore in Q4

Ruchika Sharma3 Jun 2020 9:45 AM IST

As per the MAT March''20 report of Nielsen, Glucon-D, Nycil, Everyuth Scrub and Everyuth Peel Off Mask continued to hold the number one position

Trademark Infringement: Firm Restrained By HC From Launching Hand Sanitizer Named DEVTOL

Ruchika Sharma2 Jun 2020 4:36 PM IST

The order came on a suit by Reckitt Benckiser (India) Pvt Ltd seeking a permanent injunction against Mohit Petrochemicals Pvt Ltd for selling hand...

Bharat Biotech CEO Expresses Satisfaction Over Progress of COVID-19 Vaccine Development Research

Ruchika Sharma2 Jun 2020 2:31 PM IST

Bharat Biotech CEO expressed satisfaction on the progress of the research connected with vaccine development so far, but insisted "in science, things...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Roche gets ICMR approval for COVID-19 antibody test

Ruchika Sharma2 Jun 2020 2:01 PM IST

The Roche Elecsys Anti-SARS-CoV-2 serology test that supports the detection of antibodies against SARS-CoV- 2 has received the Import License issued...

CDSCO shows green flag to Gilead Sciences to market COVID-19 drug Remdesivir

Ruchika Sharma2 Jun 2020 11:50 AM IST

"The drug, which is administered in the form of an injection, has been approved to be sold by retail on the prescription of specialists for use in the...

Union Minister Piyush Goyal lauds Pharma Industry for rising during COVID crisis

Ruchika Sharma1 Jun 2020 6:08 PM IST

New Delhi: The Commerce and Industry Minister Shri Piyush Goyal has interacted with the captains of the Pharmaceutical Industry, and Office-bearers of...

Insulin Device Patent Row: Biocon, Mylan Get Favourable Ruling from US Patent Board

Ruchika Sharma1 Jun 2020 5:03 PM IST

Bengaluru: Biocon Ltd. has announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan, Biocon's partner in inter...

Sanofi halts enrolling COVID-19 patients in hydroxychloroquine trials

Ruchika Sharma1 Jun 2020 3:08 PM IST

The moves come after the World Health Organization paused its large trial of hydroxychloroquine, prompting several European governments to ban the use...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok